Esophagitis, Peptic: all 316 studies
Page 1 of 4. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.
- SPADE Clinical Trial.RecruitingNCT07892183Not applicable
- PPI Dosing Per CYP2C19 GenotypeNot yet recruitingNCT07843264Phase 4
- Preoperative Predictors of Symptom Improvement After Laparoscopic FundoplicationRecruitingNCT07809620
- Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract ReconstructionNot yet recruitingNCT07800819
- A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)RecruitingNCT07755384
- Pilot Study of Salivary Bile Acids and Pepsin as Predictive Biomarkers of Reflux Disease After Sleeve GastrectomyNot yet recruitingNCT07607067
- Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERDNot yet recruitingNCT07178821Not applicable
- A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.RecruitingNCT07010107Phase 3
- A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux EsophagitisRecruitingNCT06850480Phase 3
- Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal GastrectomyNot yet recruitingNCT06741501Not applicable
- The Influence of Concomitant Irritable Bowel Syndrome on Gastro-Oesophageal Reflux Disease Symptoms and Severity.Not yet recruitingNCT06615856
- The Effect of Postural Correction On Gastroesophageal Reflux DiseaseRecruitingNCT06564558Not applicable
- Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux DiseaseRecruitingNCT06564246Phase 4
- Gastroesophageal Reflux Disease Diagnostic TrialNot yet recruitingNCT06504134
- Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal GastrectomyRecruitingNCT06475170Not applicable
- Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD TreatmentRecruitingNCT06348420Not applicable
- Role of Mucosal Impedance Measurement for the Diagnosis of Gastroesophageal Reflux DiseaseRecruitingNCT06339801
- Stellate Ganglion Block on Gastroesophageal Reflux DiseaseNot yet recruitingNCT06319521Not applicable
- Effect of Lidocaine Block on Gastroesophageal Reflux DiseaseNot yet recruitingNCT06304142Not applicable
- Endoloop Mediated Cardioplication to Treat Gastroesophageal Reflux DiseaseNot yet recruitingNCT06153901Not applicable
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)RecruitingNCT06121830Phase 3
- Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux DiseaseNot yet recruitingNCT06106100Not applicable
- Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal GastrectomyNot yet recruitingNCT06062225Not applicable
- Jinghua Weikang Capsule in the Treatment of Reflux EsophagitisNot yet recruitingNCT06056973Phase 4
- Nursing Teaching Scheme for Patients With Gastroesophageal Reflux DiseaseNot yet recruitingNCT05937204Not applicable
- Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux DiseaseNot yet recruitingNCT05900687Not applicable
- Anti-Reflux Mucosal Ablation(ARMA) and Anti-Reflux Mucosectomy(ARMS) in Gastroesophageal Reflux DiseaseNot yet recruitingNCT05422404Not applicable
- Clinical Trial of Reconstruction After Proximal GastrectomyNot yet recruitingNCT05418920Not applicable
- Long Term Incidence and Effect of de Novo GERD After Laparoscopic Sleeve Gastrectomy in Chinese PopulationRecruitingNCT04237857
- Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI AloneRecruitingNCT04130659Not applicable
- Endoscopic Fundoplication With MUSE SystemRecruitingNCT03669874
- Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor TherapyRecruitingNCT03596476Not applicable
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's RegistryRecruitingNCT00574327
- A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT06106022Phase 1Results posted
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT05343364Phase 1Results posted
- Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESHCompletedNCT03735862Results posted
- Precision Approach to PPI Therapy in Gastroesophageal Reflux DiseaseCompletedNCT03619811Not applicableResults posted
- Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)CompletedNCT03561883Phase 3Results posted
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)TerminatedNCT03561090Phase 3Results posted
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCompletedNCT03553563Phase 3Results posted
- Fexofenadine Use in Gastroesophageal Reflux SymptomsTerminatedNCT03425097Phase 2Results posted
- Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"CompletedNCT03214952Results posted
- Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"CompletedNCT03214081Results posted
- Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory EvaluationCompletedNCT03116841Phase 4Results posted
- Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)CompletedNCT02954848Phase 3Results posted
- Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux DiseaseCompletedNCT02706938Not applicableResults posted
- A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedNCT02637557Phase 2Results posted
- Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal MicrobiomeCompletedNCT02513784Not applicableResults posted
- The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology DepartmentCompletedNCT02506634Results posted
- LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve GastrectomyCompletedNCT02429830Not applicableResults posted
- Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCompletedNCT02351960Phase 4Results posted
- A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesCompletedNCT02153398Phase 3Results posted
- A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease PatientsCompletedNCT02135107Phase 3Results posted
- Influence of IPV on GOR in Infants From 0 to 12 Months.CompletedNCT02124863Not applicableResults posted
- Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia SymptomsCompletedNCT01990339Results posted
- Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERDCompletedNCT01882088Phase 4Results posted
- Gastroesophageal Reflux Treatment in SclerodermaCompletedNCT01878526Phase 3Results posted
- Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)CompletedNCT01669811Phase 3Results posted
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsCompletedNCT01642602Phase 2Results posted
- Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux DiseaseStatus unknownNCT01504971Results posted
- Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux DiseaseCompletedNCT01493089Phase 3Results posted
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT01472939Phase 2Results posted
- To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCompletedNCT01397084Phase 4Results posted
- Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF StudyTerminatedNCT01327963Not applicableResults posted
- Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT01045096Phase 1Results posted
- A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May ExperienceCompletedNCT01043185Phase 2Results posted
- An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux EsophagitisCompletedNCT01008696Phase 4Results posted
- Gastroesophageal Reflux Disease (GERD) Before and After Gastric BypassCompletedNCT00951093Results posted
- Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00911534Phase 3Results posted
- Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)CompletedNCT00868296Phase 3Results posted
- Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCompletedNCT00847808Phase 3Results posted
- Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCompletedNCT00847210Phase 1Results posted
- Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00838526Phase 3Results posted
- A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric PatientsCompletedNCT00787891Phase 3Results posted
- Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux EsophagitisCompletedNCT00770913Phase 2/3Results posted
- Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)CompletedNCT00734747Phase 3Results posted
- A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)CompletedNCT00734097Phase 4Results posted
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic EsophagitisCompletedNCT00728481Phase 2/3Results posted
- Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot StudyCompletedNCT00693225Phase 4Results posted
- Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study USCompletedNCT00660660Phase 4Results posted
- Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658775Phase 3Results posted
- Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658632Phase 3Results posted
- Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658528Phase 3Results posted
- Reflux Esophagitis Phase III Study (Maintenance Treatment)CompletedNCT00634114Phase 3Results posted
- Reflux Esophagitis Phase III Study (Initial Treatment)CompletedNCT00633932Phase 3Results posted
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnCompletedNCT00627016Phase 3Results posted
- Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)CompletedNCT00561730Results posted
- A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mgCompletedNCT00464308Phase 4Results posted
- Symptom Improvements in Gastroesophageal Reflux Disease (GERD) PatientsCompletedNCT00394472Phase 2Results posted
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)CompletedNCT00373334Phase 3Results posted
- Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedNCT00365300Phase 3Results posted
- Endoscopic Implantation of Enteryx for the Treatment of GERDCompletedNCT00346905Not applicableResults posted
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux DiseaseCompletedNCT00321984Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00321737Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255164Phase 3Results posted
- Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255151Phase 3Results posted
- Esomeprazole (NEXIUM) vs. SurgeryCompletedNCT00251927Phase 3Results posted
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251758Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251745Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCompletedNCT00251719Phase 3Results posted